Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is Hospiras role in the biogenerics market?

biogenerics hospira market
0
Posted

What is Hospiras role in the biogenerics market?

0

In early 2008, Hospira became the first U.S. company to sell a biogeneric in Europe when it launched Retacrit (epoetin zeta) in Germany. Retacrit is now available in more than a dozen European countries.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123